Brief: Eiko Lifesciences Ltd Says Buys 51% Of SSM Formulations
11/12/2025 05:13
Dec 11 (Reuters) - Eiko Lifesciences Ltd EIKO.BO: BUYS 51% OF SSM FORMULATIONS DEAL FOR 180 MILLION RUPEES Source text: ID:nBSE18s7Tg Further company coverage: EIKO.BO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eiko Lifesciences
See all newsBrief: Eiko Lifesciences To Buy 51% Stake In SSM Formulations
Brief: Eiko Lifesciences Ltd Says Buys 51% Of SSM Formulations
Brief: Eiko Lifesciences Says Proposal To Raise Funds Via Equity, Convertible Securities, Warrants
India's Eiko Lifesciences jumps on foray into logistics business
Brief: Eiko Lifesciences Announces Strategic Diversification Into Logistics And Container Management